LOS ANGELES–(BUSINESS WIRE)–Medacta® International, the family-owned global leader in innovative joint replacement and spinal technologies, announces today the appointment of long-time commercial leader Daniel Abromowitz as General Manager, Spine Division for Medacta USA. In addition, the company announced its MySpine Midline Cortical Pedicle Screw Placement Guide (MySpine MC), a patient-matched technology for posterior lumbar fusions, is now generally available and will be on display at the North American Spine Society (NASS) 2018 Annual Meeting, held Sept. 26-29, 2018 in Los Angeles, at Booth #2323.
“Daniel is a welcomed addition to the management team, bringing an innovative management approach and broad engineering and supply chain experience,” said Eric Dremel, President of Medacta USA. “Most importantly, Daniel’s track record of sustained commercial success and relentless customer focus will allow the potential of our Spine Division to be fully realized.”
A respected business leader, Abromowitz brings to Medacta USA a history of building high-performing, results-driven teams, with more than a decade of experience supporting and leading early-stage and emerging companies in the medical device and health care marketplaces. After nine years with spinal implant company X-spine Systems, Inc., Daniel was the Vice President of Sales when the company was acquired by Bacterin in 2015. Since, he has held senior leadership positions at Xtant Medical (formerly X-spine), Aerobiotix and most recently, Captiva Spine.
“As a passionate supporter of collaborative worldwide innovation, Medacta International offers an incredible growth opportunity for spine in the U.S. market. My goal is to build on the successful foundation of Medacta’s joint division here in the U.S. to support our key stakeholders in spine: surgeons, patients, facilities and agents,” Abromowitz said. “By utilizing the Medacta Orthopaedic Research and Education (M.O.R.E.) Institute, Medacta surgeons are never alone. I hope to expand on these peer-to-peer training programs for spinal surgeons here in the U.S., as we build Medacta USA Spine into an innovative leader for the U.S. market.”
MySpine MC – Offering a new approach to posterior lumbar fusion
The patient-matched, 3D-printed MySpine MC, first announced in May 2018, guides pedicle screws to a trajectory that evolved from the well-established cortical bone trajectory (CBT). The MySpine MC technique, however, has a more caudomedial entry point than traditional pedicle screw trajectories and a less extreme caudal-cranial angle than CBT to avoid interference with the cranial facet joints and to accommodate larger screw diameters and lengths, precisely supported by 3D pre-operative planning. As an accurate and reliable muscle-sparring approach, MySpine MC is designed to encourage faster patient recovery and is suitable for both inpatient and outpatient surgery settings.
MySpine MC will be on display at NASS 2018 at Booth #2323 along with the rest of Medacta’s spine product portfolio. For more information on MySpine MC, visit Medacta’s MySpine MC webpage, where the new MySpine MC video is available.
About Medacta International
Medacta® International is a world leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS® system and total knee replacement with MyKnee® patient-matched technology. Over the last 10 years, Medacta has grown dramatically by taking a different approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 30 countries. To learn more about Medacta International, please visit www.medacta.com or follow @Medacta on Twitter.
For Medacta International
Jill Bongiorni, 516-729-2250